Page last updated: 2024-08-26

arsenic and Chronic Hepatitis C

arsenic has been researched along with Chronic Hepatitis C in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (66.67)29.6817
2010's1 (33.33)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chen, CJ; Chen, CL; Chiou, HY; Hsieh, FI; Hsu, KH; Hsu, LI; Liu, CT; Wang, YH; Wen-Juei Jeng, R; Wu, MM; Yang, TY1
Yu, MC; Yuan, JM1
Bakulin, IG; Ivanova, MA; Novozhenov, VG1

Reviews

1 review(s) available for arsenic and Chronic Hepatitis C

ArticleYear
Environmental factors and risk for hepatocellular carcinoma.
    Gastroenterology, 2004, Volume: 127, Issue:5 Suppl 1

    Topics: Aflatoxins; Alcohol Drinking; Antioxidants; Arsenic; Carcinoma, Hepatocellular; Contraceptives, Oral; Diabetes Complications; Hepacivirus; Hepatitis B virus; Hepatitis B, Chronic; Hepatitis C, Chronic; Humans; Liver Cirrhosis; Liver Neoplasms; Obesity; Risk Factors; Smoking

2004

Other Studies

2 other study(ies) available for arsenic and Chronic Hepatitis C

ArticleYear
Effects of Arsenic in Drinking Water on Risk of Hepatitis or Cirrhosis in Persons With and Without Chronic Viral Hepatitis.
    Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association, 2016, Volume: 14, Issue:9

    Topics: Aged; Arsenicals; DNA, Viral; Drinking Water; Female; Hepatitis B Surface Antigens; Hepatitis B, Chronic; Hepatitis C Antibodies; Hepatitis C, Chronic; Humans; Liver Cirrhosis; Male; Middle Aged; Risk Assessment; Taiwan

2016
[The possibilities of element status evaluation in determination of antiviral therapy resistance in patients with chronic hepatitis C].
    Voenno-meditsinskii zhurnal, 2006, Volume: 327, Issue:8

    Topics: Adult; Antiviral Agents; Arsenic; Case-Control Studies; Drug Resistance, Viral; Drug Therapy, Combination; Elements; Female; Hepacivirus; Hepatitis C, Chronic; Humans; Interferon alpha-2; Interferon-alpha; Male; Metals; Middle Aged; Phosphorus; Recombinant Proteins; Treatment Outcome

2006